Latest in Astrazeneca’s
Sort by
14 items
-
China has trapped the tiger of AstraZeneca’s growth
The UK pharmaceutical company needs to resolve a corruption crackdown affecting senior executivesWorld - Financial Times - November 14 -
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.Business - CNBC - November 13 -
AstraZeneca says it takes China investigation ‘very seriously’
UK’s biggest pharmaceutical company ‘committed to China’ as it raises 2024 profit forecast and announces $3.5bn US investment. Business live – latest updates AstraZeneca’s chief executive has ...World - The Guardian - November 12 -
AstraZeneca embarks on major US expansion
UK’s largest drugmaker to invest $3.5bn by end of 2026 as it targets doubling of revenuesBusiness - Financial Times - November 12 -
China fright ups the stakes for AstraZeneca
Pharma group needs some good news to ease investors’ nervesWorld - Financial Times - November 7 -
China Has Detained a Senior AstraZeneca Executive
Leon Wang, executive vice president in charge of China and the broader Asian region, is being detained while the Chinese government is probing AstraZeneca employees, the drugmaker says.Business - The Wall Street Journal - November 6 -
AstraZeneca’s top China executive detained by authorities
Pharmaceutical group confirms four other current and ex-executives investigated, in addition to Leon WangWorld - Financial Times - November 6 -
AstraZeneca shares fall as China probe intensifies
Investigation of group’s China chief Leon Wang comes after several employees were found guilty of fraudWorld - Financial Times - November 5 -
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.Business - MarketWatch - November 5 -
AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
An investigation involving the drugmaker’s China president is the latest crackdown to trigger uncertainty in the industry about Beijing’s intentions.Business - The Wall Street Journal - October 31 -
UK borrowing costs rise as Reeves’ spending plans unnerve investors
Ten-year gilt yield hits five-month high after chancellor’s first BudgetBusiness - Financial Times - October 30 -
AstraZeneca China president under investigation by Chinese authorities
British drugmaker says Leon Wang is ‘co-operating with an ongoing investigation’Business - Financial Times - October 30
